NewGenIvf Group Ltd

Análisis de la acción NewGenIvf Group Ltd (NIVF)

$1.330

-0.019 (-1.42%)Al cierre

Loading chart…
High
1.400
Open
1.355
VWAP
1.34
Vol
63.10K
Mkt Cap
Low
1.300
Amount
84.77K
EV/EBITDA, TTM
-0.01

NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.

newgenivf.com

AI analysis of NewGenIvf Group Ltd (NIVF)

sell

NIVF is not a good buy right now due to its significant price decline and poor financial performance. The current price is $0.42, with a year-to-date change of -98.25%, indicating severe underperformance. Additionally, the RSI is at 25.414, suggesting the stock is oversold but may not rebound soon given the negative trends in revenue and net income.

Métricas de valoración

The current forward P/E ratio for NewGenIvf Group Ltd (NIVF) is 0.03, compared to its 5-year average forward P/E of 0.07.

Forward P/E

Fair
5Y Average P/E
0.07
Current P/E
0.03
Sobrevalorada
0.31
Infravalorada
-0.16

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.23
Current EV/EBITDA
-0.01
Sobrevalorada
0.60
Infravalorada
-1.06

Forward P/S

Fair
5Y Average P/S
0.01
Current P/S
0.01
Sobrevalorada
0.02
Infravalorada
-0.01

Alphio AI Price Scenarios for NIVF

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%NIVF

$0.57

Precio del escenario

B

Base

Base · 50%NIVF

$0.57

Precio del escenario

B

Bear

Bear · 25%NIVF

$0.56

Precio del escenario

Cronología de eventos

2026-08-31 (ET)

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

2026-07-27 (ET)

09:30:00

NewGenIVF Acquires 3% Stake in K25.ai for $7.5M

2026-07-02 (ET)

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

2026-06-18 (ET)

09:00:00

NewGenIVF Invests Additional $4M in K25.ai

2026-06-04 (ET)

09:10:00

NewGenIVF Commits Additional $4M to K25.ai, Total Investment Reaches $6M

Noticias

NIVF FAQ — answered by Alphio AI

NewGenIVF Group Limited is a diversified healthcare and technology-driven platform focused on investments across fertility services, consumer wellness, digital assets, and real estate. The Company operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia. It operates in the Healthcare sector.

NIVF is not a good buy right now due to its significant price decline and poor financial performance. The current price is $0.42, with a year-to-date change of -98.25%, indicating severe underperformance. Additionally, the RSI is at 25.414, suggesting the stock is oversold but may not rebound soon given the negative trends in revenue and net income.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis